ArticleJournal of gastrointestinal oncology2025
Comparison analysis of different doses bevacizumab plus ICIs and interventional therapy in unresectable hepatocellular carcinoma: a real-world study.
Miao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.